Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines.
Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines.
复制标题
组蛋白去乙酰化酶抑制剂panobinostat在颗粒细胞肿瘤细胞系中发挥抗增殖作用,并从异常表观遗传状态部分正常化。
DOI:
10.1371/journal.pone.0271245
复制
发表时间:
2022
期刊:
影响因子:
3.7
通讯作者:
Shimoya, Koichiro
中科院分区:
文献类型:
--
作者:
Hazama, Yukiko;Tsujioka, Takayuki;Kitanaka, Akira;Tohyama, Kaoru;Shimoya, Koichiro
The prognosis of the patients with inoperable or advanced granulosa cell tumors (GCTs) is still poor, and therefore it is important to establish a novel treatment strategy. Here we investigated the in vitro effects of a histone deacetylase inhibitor, panobinostat (PS) on two GCT cell lines (KGN and COV434). GCT cell lines were found to be susceptible to PS treatment and it inhibited cell growth mainly by apoptosis. In cell cycle analysis, PS reduced only the ratio of S phase in GCT cell lines. Combined treatment of PS with a deubiquitinase inhibitor, VLX1570 enhanced the expression of p21, cleaved PARP, cleaved caspase-9, heme oxygenase-1, and the acetylation of histone H4 and α-tubulin, leading to an additive anti-proliferative effect on KGN and COV434. The gene set enrichment analysis revealed that PS treatment suppressed DNA replication- or cell cycle-related gene expression which led to chemotherapeutic cell death and in addition, this treatment induced activation of the gene set of adherens junction towards a normalized direction as well as activation of neuron-related gene sets that might imply unexpected differentiation potential due to epigenetic modification by a HDAC inhibitor in KGN cells. Exposure of KGN and COV434 cells to PS increased the expression of E-cadherin, one of the principal regulators associated with adherens junction in quantitative RT-PCR and immunoblotting analysis. In the present study, we indicate a basis of a novel therapeutic availability of a HDAC inhibitor for the treatment of GCTs and further investigations will be warranted.
登录
查看更多内容
影响因子:
64.5
作者:
Kawaguchi, Y;Kovacs, JJ;Yao, TP
通讯作者:
Yao, TP
DOI:
10.1083/jcb.143.7.1883
发表时间:
1998-12-28
期刊:
The Journal of cell biology
影响因子:
--
作者:
Johnston JA;Ward CL;Kopito RR
通讯作者:
Kopito RR
影响因子:
20.3
作者:
Catley, Laurence;Weisberg, Ellen;Anderson, Kenneth C.
通讯作者:
Anderson, Kenneth C.
影响因子:
5.7
作者:
Hui, Kwai Fung;Lam, Benjamin H. W.;Chiang, Alan K. S.
通讯作者:
Chiang, Alan K. S.
影响因子:
3.4
作者:
Budman, Daniel R.;Tai, Julia;John, Veena
通讯作者:
John, Veena